• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13D/A filed by NeueHealth Inc.

    10/6/25 5:00:02 PM ET
    $NEUE
    Medical Specialities
    Health Care
    Get the next $NEUE alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 3)


    NeueHealth, Inc.

    (Name of Issuer)


    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)


    10920V404

    (CUSIP Number)


    Jennifer Y. Ishiguro
    StepStone Group LP, 4225 Executive Square, Suite 1600
    La Jolla, CA, 90237
    (858) 558-9700

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    10/02/2025

    (Date of Event Which Requires Filing of This Statement)


    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    SCHEDULE 13D

    CUSIP No.
    10920V404


    1 Name of reporting person

    StepStone Group LP
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    AF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    0.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    0 %
    14Type of Reporting Person (See Instructions)

    PN



    SCHEDULE 13D

    CUSIP No.
    10920V404


    1 Name of reporting person

    StepStone VC Global Partners VII, L.P.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    0.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    0 %
    14Type of Reporting Person (See Instructions)

    PN



    SCHEDULE 13D

    CUSIP No.
    10920V404


    1 Name of reporting person

    StepStone VC Global Partners VII-B, L.P.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    0.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    0 %
    14Type of Reporting Person (See Instructions)

    PN



    SCHEDULE 13D

    CUSIP No.
    10920V404


    1 Name of reporting person

    StepStone VC Global Partners VII-D, L.P.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    0.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    0 %
    14Type of Reporting Person (See Instructions)

    PN



    SCHEDULE 13D

    CUSIP No.
    10920V404


    1 Name of reporting person

    StepStone VC Global Partners VII-S, L.P.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    0.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    0 %
    14Type of Reporting Person (See Instructions)

    PN



    SCHEDULE 13D

    CUSIP No.
    10920V404


    1 Name of reporting person

    StepStone VC Opportunities IV, L.P.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    0.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    0 %
    14Type of Reporting Person (See Instructions)

    PN



    SCHEDULE 13D

    CUSIP No.
    10920V404


    1 Name of reporting person

    StepStone Master G, L.P.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    0.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    0 %
    14Type of Reporting Person (See Instructions)

    PN



    SCHEDULE 13D

    CUSIP No.
    10920V404


    1 Name of reporting person

    AU Special Investments, L.P.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    0.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    0 %
    14Type of Reporting Person (See Instructions)

    PN



    SCHEDULE 13D

    CUSIP No.
    10920V404


    1 Name of reporting person

    StepStone VC Opportunities VI, L.P.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    0.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    0 %
    14Type of Reporting Person (See Instructions)

    PN



    SCHEDULE 13D

    CUSIP No.
    10920V404


    1 Name of reporting person

    StepStone VC Opportunities VI-D, L.P.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    0.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    0 %
    14Type of Reporting Person (See Instructions)

    PN



    SCHEDULE 13D

    CUSIP No.
    10920V404


    1 Name of reporting person

    StepStone VC Opportunities V, L.P.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    0.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    0 %
    14Type of Reporting Person (See Instructions)

    PN



    SCHEDULE 13D

    CUSIP No.
    10920V404


    1 Name of reporting person

    StepStone Opportunities V-D, L.P.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    0.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    0 %
    14Type of Reporting Person (See Instructions)

    PN



    SCHEDULE 13D

    Item 1.Security and Issuer
    (a)Title of Class of Securities:

    Common Stock, par value $0.0001 per share
    (b)Name of Issuer:

    NeueHealth, Inc.
    (c)Address of Issuer's Principal Executive Offices:

    9250 NW 36th St, Suite 420, Doral, FLORIDA , 33178.
    Item 5.Interest in Securities of the Issuer
    (a)
    Item 5 of the Schedule 13D is amended and supplemented as follows: The information set forth in rows 11 and 13 of the cover pages to this Schedule 13D is incorporated by reference.
    (b)
    The information set forth in rows 7 through 10 of the cover pages to this Schedule 13D is incorporated by reference.
    (c)
    Except for the information set forth in Item 5(e) hereof, which is incorporated by reference, none of the Reporting Persons has effected any transaction in the Common Stock during the last 60 days.
    (e)
    On October 2, 2025, all of the shares of Common Stock held by the Reporting Persons were canceled and extinguished and automatically converted into the right to receive cash in an amount equal to $7.33 per share in connection with the Issuer's previously announced business combination. As a result, each of the Reporting Persons ceased to be the beneficial owner of more than five percent of the Common Stock.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    StepStone Group LP
     
    Signature:/s/ Jennifer Y. Ishiguro
    Name/Title:By: StepStone Group Holdings LLC, its General Partner, by Jennifer Y. Ishiguro, Partner, Chief Legal Officer
    Date:10/06/2025
     
    StepStone VC Global Partners VII, L.P.
     
    Signature:/s/ Jennifer Y. Ishiguro
    Name/Title:By: StepStone Group LP, its investment manager, by Stepstone Group Holdings LLC, its general partner, by Jennifer Y. Ishiguro, Partner, CLO
    Date:10/06/2025
     
    StepStone VC Global Partners VII-B, L.P.
     
    Signature:/s/ Jennifer Y. Ishiguro
    Name/Title:By: StepStone Group LP, its investment manager, by Stepstone Group Holdings LLC, its general partner, by Jennifer Y. Ishiguro, Partner, CLO
    Date:10/06/2025
     
    StepStone VC Global Partners VII-D, L.P.
     
    Signature:/s/ Jennifer Y. Ishiguro
    Name/Title:By: StepStone Group LP, its investment manager, by Stepstone Group Holdings LLC, its general partner, by Jennifer Y. Ishiguro, Partner, CLO
    Date:10/06/2025
     
    StepStone VC Global Partners VII-S, L.P.
     
    Signature:/s/ Jennifer Y. Ishiguro
    Name/Title:By: StepStone Group LP, its investment manager, by Stepstone Group Holdings LLC, its general partner, by Jennifer Y. Ishiguro, Partner, CLO
    Date:10/06/2025
     
    StepStone VC Opportunities IV, L.P.
     
    Signature:/s/ Jennifer Y. Ishiguro
    Name/Title:By: StepStone Group LP, its investment manager, by Stepstone Group Holdings LLC, its general partner, by Jennifer Y. Ishiguro, Partner, CLO
    Date:10/06/2025
     
    StepStone Master G, L.P.
     
    Signature:/s/ Jennifer Y. Ishiguro
    Name/Title:By: StepStone Group LP, its investment manager, by Stepstone Group Holdings LLC, its general partner, by Jennifer Y. Ishiguro, Partner, CLO
    Date:10/06/2025
     
    AU Special Investments, L.P.
     
    Signature:/s/ Jennifer Y. Ishiguro
    Name/Title:By: StepStone Group LP, its investment manager, by Stepstone Group Holdings LLC, its general partner, by Jennifer Y. Ishiguro, Partner, CLO
    Date:10/06/2025
     
    StepStone VC Opportunities VI, L.P.
     
    Signature:/s/ Jennifer Y. Ishiguro
    Name/Title:By: StepStone Group LP, its investment manager, by Stepstone Group Holdings LLC, its general partner, by Jennifer Y. Ishiguro, Partner, CLO
    Date:10/06/2025
     
    StepStone VC Opportunities VI-D, L.P.
     
    Signature:/s/ Jennifer Y. Ishiguro
    Name/Title:By: StepStone Group LP, its investment manager, by Stepstone Group Holdings LLC, its general partner, by Jennifer Y. Ishiguro, Partner, CLO
    Date:10/06/2025
     
    StepStone VC Opportunities V, L.P.
     
    Signature:/s/ Jennifer Y. Ishiguro
    Name/Title:By: StepStone Group LP, its investment manager, by Stepstone Group Holdings LLC, its general partner, by Jennifer Y. Ishiguro, Partner, CLO
    Date:10/06/2025
     
    StepStone Opportunities V-D, L.P.
     
    Signature:/s/ Jennifer Y. Ishiguro
    Name/Title:By: StepStone Group LP, its investment manager, by Stepstone Group Holdings LLC, its general partner, by Jennifer Y. Ishiguro, Partner, CLO
    Date:10/06/2025
    Get the next $NEUE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NEUE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NEUE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NeueHealth Announces Closing of Take-Private Transaction

    NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today announced the successful closing of its previously announced merger under which NeueHealth has been acquired by an affiliate of New Enterprise Associates ("NEA") at an enterprise value of approximately $1.465 billion. Under the terms of the merger agreement, holders of NeueHealth common stock (other than shares that will be rolled over and certain excluded shares) will receive $7.33 per share in cash. Certain stockholders of NeueHeath, including NEA and 12 existing NeueHealth investors (which collectively hold all of the outstanding shares of NeueHealth preferred stock), have entered i

    10/2/25 9:16:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    NeueHealth Reports Second Quarter 2025 Results

    Delivered strong second quarter financial results, reflecting the continued success of consumer-centric care model and ability to create value for consumers, payors, and providers across the industry Drove positive Adjusted EBITDA for the sixth consecutive quarter, placing the company in a strong position to drive long-term, sustainable growth this year and beyond Served approximately 694,000 consumers, an increase of 45% over the second quarter of 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its second quarter ended June 30, 2025. "We are pleased to report another strong quarter of f

    8/7/25 6:45:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    NeueHealth to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025

    NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report second quarter financial results before the financial markets open on Thursday, August 7, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests parti

    7/17/25 8:00:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    $NEUE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Matushak Jay returned 40,431 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - NeueHealth, Inc. (0001671284) (Issuer)

    10/14/25 7:54:57 PM ET
    $NEUE
    Medical Specialities
    Health Care

    Large owner Bessemer Venture Partners Ix L.P. returned 999,218 shares to the company (SEC Form 4)

    4 - NeueHealth, Inc. (0001671284) (Issuer)

    10/6/25 7:45:32 PM ET
    $NEUE
    Medical Specialities
    Health Care

    Director Kraus Stephen returned 16,443 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - NeueHealth, Inc. (0001671284) (Issuer)

    10/6/25 7:35:04 PM ET
    $NEUE
    Medical Specialities
    Health Care

    $NEUE
    SEC Filings

    View All

    SEC Form 15-12G filed by NeueHealth Inc.

    15-12G - NeueHealth, Inc. (0001671284) (Filer)

    10/14/25 6:02:35 AM ET
    $NEUE
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13D/A filed by NeueHealth Inc.

    SCHEDULE 13D/A - NeueHealth, Inc. (0001671284) (Subject)

    10/6/25 5:00:02 PM ET
    $NEUE
    Medical Specialities
    Health Care

    SEC Form S-8 POS filed by NeueHealth Inc.

    S-8 POS - NeueHealth, Inc. (0001671284) (Filer)

    10/2/25 11:02:08 AM ET
    $NEUE
    Medical Specialities
    Health Care

    $NEUE
    Financials

    Live finance-specific insights

    View All

    NeueHealth Reports Second Quarter 2025 Results

    Delivered strong second quarter financial results, reflecting the continued success of consumer-centric care model and ability to create value for consumers, payors, and providers across the industry Drove positive Adjusted EBITDA for the sixth consecutive quarter, placing the company in a strong position to drive long-term, sustainable growth this year and beyond Served approximately 694,000 consumers, an increase of 45% over the second quarter of 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its second quarter ended June 30, 2025. "We are pleased to report another strong quarter of f

    8/7/25 6:45:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    NeueHealth to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025

    NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report second quarter financial results before the financial markets open on Thursday, August 7, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests parti

    7/17/25 8:00:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    NeueHealth Reports First Quarter 2025 Results

    Delivered strong first quarter performance as care model continues to resonate with consumers, providers, and payors across the healthcare industry Drove positive Adjusted EBITDA for the fifth consecutive quarter, providing a strong foundation for continued success in 2025 and beyond Served approximately 709,000 consumers, an increase of 51% over the first quarter of 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its first quarter ended March 31, 2025. "We are starting 2025 in a very strong position, generating substantial growth in the number of consumers we serve and delivering another

    5/8/25 6:45:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    $NEUE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by NeueHealth Inc. (Amendment)

    SC 13D/A - NeueHealth, Inc. (0001671284) (Subject)

    4/10/24 9:52:09 PM ET
    $NEUE
    Medical Specialities
    Health Care